Actavis to pay $84 million to end Medicaid fraud case



The AP (12/28) reported, “Texas has reached an $84 million settlement with Actavis Inc., the prescription drug maker convicted of inflating drug prices to the Medicaid program.” Prosecutors alleged that “Actavis inaccurately reported its prices, leading Medicaid to overpay pharmacies.” The case “followed a whistleblower suit filed more than 10 years ago by a small pharmacy in Florida and was the only one of several similar cases to reach a jury.” Excerpt from AAJ News Brief.


This entry was posted in Current Events, False Claims, Government Fraud. Bookmark the permalink.

Comments are closed.